| Identification | Back Directory | [Name]
VRT752271 | [CAS]
869886-67-9 | [Synonyms]
CS-725
VRT752271
Padsevonil
Ulixertinib
VRT752271 HCl
BVD-523 ( VRT752271)
Ulixertinib (BVD-523)
Ulixertinib, VRT752271
VRT-752271(Ulixertinib)
Ulixertinib (BVD-523,VRT752271)
BVD-523, BVD 523, BVD523, VRT752271, VRT752271, VRT 752271, ULIXERTINIB
BVD-523; BVD 523; BVD523; ULIXERTINIB; VRT752271; VRT-752271; VRT 752271
(S)-4-(5-chloro-2-(isopropylamino)pyridin-4-yl)-N-(1-(3-chlorophenyl)-2-hydroxyethyl)-1H-pyrrole-2-carboxamide
N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-4-[5-chloro-2-(propan-2-ylamino)pyridin-4-yl]-1H-pyrrole-2-carboxamide
4-(5-Chloro-2-isopropylamino-4-pyridinyl)pyrrole-2-carboxylic acid (S)-[1-(3-chlorophenyl)-2-hydroxyethyl]amide HCl
4-[5-Chloro-2-[(1-methylethyl)amino]-4-pyridinyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-1H-pyrrole-2-carboxamide
1H-Pyrrole-2-carboxaMide, 4-[5-chloro-2-[(1-Methylethyl)aMino]-4-pyridinyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-
4-[5-Chloro-2-[(1-methylethyl)amino]-4-pyridinyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-1H-pyrrole-2-carboxamide VRT752271 | [Molecular Formula]
C21H22Cl2N4O2 | [MDL Number]
MFCD22628898 | [MOL File]
869886-67-9.mol | [Molecular Weight]
433.33 |
| Chemical Properties | Back Directory | [Boiling point ]
682.8±55.0 °C(Predicted) | [density ]
1.359 | [storage temp. ]
Store at -20°C | [solubility ]
DMSO:93.0(Max Conc. mg/mL);214.62(Max Conc. mM)
Ethanol:43.0(Max Conc. mg/mL);99.23(Max Conc. mM) | [form ]
Powder | [pka]
13.34±0.50(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
Ulixertinib is a potent and reversible ERK1/ERK2 inhibitor with IC50 of <0.3 nM for ERK2. Inhibits cell proliferation. Anti-cancer. | [storage]
Store at -20°C |
|
|